Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderRecruiting
NCT07282665Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Clostridoides Difficile Associated Disease
United States, Argentina, Japan, United Kingdom
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary FibrosisNot Yet Recruiting
NCT07441408Phase 3Updated Aug 14, 2026
Sponsor: Bristol-Myers Squibb
Pulmonary Fibrosis
United States, Argentina, Australia, Belgium, Brazil +22 more
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With CardiomyopathyRecruiting
NCT07052903Phase 3Updated Aug 14, 2026
Sponsor: Alnylam Pharmaceuticals
Transthyretin Amyloidosis With Cardiomyopathy
United States, Argentina, Australia, Austria, Belgium +30 more
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Active Not Recruiting
NCT05878769Phase 3Updated Aug 14, 2026
Sponsor: Hoffmann-La Roche
Chronic Obstructive Pulmonary Disease
United States, Argentina, Australia, Austria, Belgium +35 more
Heart and Blood Vessels Health in People With Cystic FibrosisNot Yet Recruiting
NCT07692594N/AUpdated Aug 14, 2026
Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust
Cystic Fibrosis (CF) · Cardiovascular (CV) Risk · Flow-mediated Dilation Evaluation of the Brachial Artery · Pulse Wave Analysis
United Kingdom
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDGActive Not Recruiting
NCT06892288Phase 2, Phase 3Updated Aug 14, 2026
Sponsor: Glycomine, Inc.
Phosphomannomutase 2 Deficiency · PMM2-CDG
United States, Belgium, Czechia, France, Germany +5 more
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)Recruiting
NCT07419295Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Bladder Cancer
United States, Argentina, Australia, Belgium, Brazil +11 more
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease DementiaRecruiting
NCT07284472Phase 2, Phase 3Updated Aug 14, 2026
Sponsor: Exciva GmbH
Agitation Associated With Alzheimer's Disease Dementia
United States, Canada, Czechia, Germany, Italy +4 more
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS TumorsActive Not Recruiting
NCT04774718Phase 1, Phase 2Updated Aug 14, 2026
Sponsor: Hoffmann-La Roche
ALK Fusion-positive Solid or CNS Tumors
United States, Australia, Brazil, Canada, China +6 more
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)Active Not Recruiting
NCT04736706Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Australia, Brazil, Canada, Chile +30 more
Balance Training Following Pulmonary Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease (COPD)Recruiting
NCT07750821NAUpdated Aug 14, 2026
Sponsor: Samantha Harrison
COPD (Chronic Obstructive Pulmonary Disease) · COPD · Balance Exercise · Falls, Intervention
United Kingdom
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Recruiting
NCT06966700Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +34 more
Urine Collection and Novel UTI Biomarkers in Children and Older AdultsNot Yet Recruiting
NCT07766278N/AUpdated Aug 14, 2026
Sponsor: Queen's University, Belfast
UTI - Urinary Tract Infection
United Kingdom
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)Active Not Recruiting
NCT01385176NAUpdated Aug 14, 2026
Sponsor: Boston Scientific Corporation
Heart Failure · Congestive Heart Failure
Belgium, Czechia, France, Germany, Italy +3 more
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Recruiting
NCT06629779Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Metastatic Castration-Resistant Prostate Cancer
United States, Argentina, Brazil, Bulgaria, Canada +22 more
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresRecruiting
NCT05077904Phase 3Updated Aug 14, 2026
Sponsor: UCB Biopharma SRL
Stereotypical Prolonged Seizures
United States, Australia, Bulgaria, China, Czechia +8 more
Phase 2 Study of SAT-3247 in Pediatric Ambulatory PatientsRecruiting
NCT07287189Phase 2Updated Aug 14, 2026
Sponsor: Satellos Bioscience, Inc.
Duchenne Muscular Dystrophy · Duchenne · DMD · Neuromuscular Diseases
United States, Australia, Belgium, Canada, Poland +3 more
A Study of TAK-755 in Adults With Acute Ischemic StrokeRecruiting
NCT07392450Phase 2Updated Aug 14, 2026
Sponsor: Takeda
Acute Ischemic Stroke
United States, Belgium, Brazil, China, France +5 more
Advance Care Planning and Care Coordination for People With Parkinson's DiseaseCompleted
NCT05954013NAUpdated Aug 14, 2026
Sponsor: Radboud University Medical Center
Parkinson Disease · Parkinsonism
Austria, Estonia, Germany, Greece, Italy +2 more
A Trial of Staff Time With Proned Patients in the ICU Using the 'BathMat'Completed
NCT06844617NAUpdated Aug 14, 2026
Sponsor: Royal United Hospitals Bath NHS Foundation Trust
Acute Respiratory Distress Syndrome (ARDS) · Proning · Intensive Care Medicine
United Kingdom
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Recruiting
NCT06152575Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Belgium, Brazil +22 more
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive CrisisRecruiting
NCT06699849Phase 2Updated Aug 14, 2026
Sponsor: CSL Behring
Sickle Cell Disease Vaso-occlusive Crisis
United States, Turkey (Türkiye), United Kingdom
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)Recruiting
NCT06824467Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
United States, Argentina, Australia, Austria, Belgium +24 more
DERMATOMICS: Identifying Regulators of Skin HomeostasisRecruiting
NCT06894654N/AUpdated Aug 14, 2026
Sponsor: Relation Therapeutics
Systemic Sclerosis (SSc)
United Kingdom
Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruiting
NCT04649242Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Pediatric Migraine
United States, Canada, China, Japan, Mexico +4 more

Previous page Next page